Volume 18 - Issue 11 - November, 2006
Feature
Original Contribution
08/01/2008
John J. Young, MD, Eugene S. Chung, MD, Santosh G. Menon, MD, Theodore Chow, MD,
Anubhav Mital, BS, *Joseph Pastore, PhD, Dean J. Kereiakes, MD
John J. Young, MD, Eugene S. Chung, ...
Early restoration of normal coronary perfusion after myocardial infarction (MI) limits infarct size, preserves left ventricular (LV) function and reduces mortality. The primary objective of reperfusion therapy is not only to restore...
Early restoration of normal coronary perfusion after myocardial infarction (MI) limits infarct size, preserves left ventricular (LV) function and reduces mortality. The primary objective of reperfusion therapy is not only to restore...
Early restoration of normal...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
aAdnan K. Chhatriwalla, MD, aMichael Ragosta, MD, bEric R. Powers, MD, aIan J. Sarembock, MD, aLawrence W. Gimple, MD, aJoshua J. Fischer, MD, cKurt G. Barringhaus, MD, dChristopher M. Kramer, MD, eHabib Samady, MD
aAdnan K. Chhatriwalla, MD, aMichael...
Myocardial fractional flow reserve (FFR) is an invasive index of the physiologic significance of a coronary stenosis. FFR is simply measured as the mean intracoronary pressure distal to a lesion divided by the mean aortic pressure during...
Myocardial fractional flow reserve (FFR) is an invasive index of the physiologic significance of a coronary stenosis. FFR is simply measured as the mean intracoronary pressure distal to a lesion divided by the mean aortic pressure during...
Myocardial fractional flow...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Tarek Helmy, MD and Richard Callihan, MD
Tarek Helmy, MD and Richard Callihan,...
The concept of fractional flow reserve (FFR) was introduced by Pijls et al in his publication in 1993.1 This concept uses pressure measurement as a surrogate for flow, in a state where resistance is minimal and constant, a state of maximal...
The concept of fractional flow reserve (FFR) was introduced by Pijls et al in his publication in 1993.1 This concept uses pressure measurement as a surrogate for flow, in a state where resistance is minimal and constant, a state of maximal...
The concept of fractional flow...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
O. Christopher Raffel, MD, Joseph C. Hannan, MD, Ik-Kyung Jang, MD, PhD
O. Christopher Raffel, MD, Joseph C....
An 82-year-old female with exertional dyspnea and a positive stress test underwent elective coronary angiography which revealed lesions in the left anterior descending coronary artery and right coronary artery (RCA). Staged percutaneous...
An 82-year-old female with exertional dyspnea and a positive stress test underwent elective coronary angiography which revealed lesions in the left anterior descending coronary artery and right coronary artery (RCA). Staged percutaneous...
An 82-year-old female with...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Ajay K. Jain, MD, Elliot J. Smith, MD, Martin T. Rothman, FRCP, FACC, FESC
Ajay K. Jain, MD, Elliot J. Smith, M...
The epicardial coronary venous system has become the subject of renewed interest in recent years. There appear to be three main domains in which a thorough understanding of the venous system may lead to potentially useful clinical...
The epicardial coronary venous system has become the subject of renewed interest in recent years. There appear to be three main domains in which a thorough understanding of the venous system may lead to potentially useful clinical...
The epicardial coronary venous...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Shaoliang Chen, MD, Zhizhong Liu, MD, Nailiang Tian, MD, Junjie Zhang, MD, Fei Yei, MD, Baoxian Duan, MD, Zhongsheng Zhu, MD, Song Lin, MD, *Tak W. Kwan, MD
Shaoliang Chen, MD, Zhizhong Liu, MD...
Myocardial infarction is the leading cause of congestive heart failure (CHF) and death in developed western countries and in China as well. The current pharmacotherapy for CHF includes neurohormonal inhibition with beta-blockers and...
Myocardial infarction is the leading cause of congestive heart failure (CHF) and death in developed western countries and in China as well. The current pharmacotherapy for CHF includes neurohormonal inhibition with beta-blockers and...
Myocardial infarction is the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Ravi K. Ramana, DO, Dominique Joyal, MD, Dinesh Arab, MD, Robert S. Dieter, MD, RVT,
Lowell Steen, MD, Bruce Lewis, MD, Ferdinand Leya, MD
Ravi K. Ramana, DO, Dominique Joyal,...
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Percutaneous coronary intervention (PCI) in patients with depressed left ventricular function requires patience, technical skills and, at times, even a counterintuitive approach. In this high-risk group, standard PCI methods, mainly balloon...
Percutaneous coronary intervention (PCI) in patients with depressed left ventricular function requires patience, technical skills and, at times, even a counterintuitive approach. In this high-risk group, standard PCI methods, mainly balloon...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Jonathan D. Marmur, MD, Shyam Poludasu, MD, Ajay Agarwal, MD, Pompeiu Vladutiu, MD,
Alan Feit, MD, Reuven Lapin, PA, Erdal Cavusoglu, MD
Jonathan D. Marmur, MD, Shyam Poluda...
Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting with acute coronary syndromes and in...
Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting with acute coronary syndromes and in...
Several large randomized...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Kent R. Nilsson, MD, MA, Shayar M. Gharacholou, MD, Michael H. Sketch, Jr., MD,
Mitchell W. Krucoff, MD
Kent R. Nilsson, MD, MA, Shayar M. G...
Case Presentation. A 55-year-old African-American male with a past medical history notable for coronary artery disease, insulin-dependent diabetes mellitus complicated by end-organ damage, hypertension and hyperlipidemia presented to our...
Case Presentation. A 55-year-old African-American male with a past medical history notable for coronary artery disease, insulin-dependent diabetes mellitus complicated by end-organ damage, hypertension and hyperlipidemia presented to our...
Case Presentation. A 55-year-old...
08/01/2008
Journal of Invasive Cardiology
